Clinical Trial Update: Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh [Phase 4]

View source ↗

Summary

Phase 4 trial assessing immunogenicity of one- and two-dose poliovirus type 2 schedule using IPV and fIPV in children aged 9-13 months in Bangladesh.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Poliomyelitis | Phase 4 | Status: UNKNOWN